This Biotech Is Experiencing A Coronavirus Surge
While it could be a year or more before a vaccine for the new coronavirus is ready for market, significant progress in the development of… Read More »This Biotech Is Experiencing A Coronavirus Surge
While it could be a year or more before a vaccine for the new coronavirus is ready for market, significant progress in the development of… Read More »This Biotech Is Experiencing A Coronavirus Surge
Amid the panic over the new coronavirus that has led to unprecedented quarantines in China, and which has now made its way to North America,… Read More »Panic Potential
The San Antonio Breast Cancer Symposium, which is being held from December 10 to 14, has become one of the biggest venues for biotech companies… Read More »2 Biotech Companies About To Publicly Reveal Details Of Their Promising Breast Cancer Drug Candidates
The sharp rise in Elizabeth Warren’s poll numbers in the Democratic presidential primary has coincided with a sharp decline in the shares of many biotech… Read More »Biotech Stocks Now Available At A “Warren Discount”
Mergers and acquisitions. Positive pipeline-related advancements. The integration of artificial intelligence. These are some of the key trends currently favoring the biotechnology sector – and… Read More »ETFs To Play Biotech’s Favorable Prognosis
With the IBB biotechnology ETF poised to have its best quarter in six years and analysts seeing further upside for the space, biotech appears to… Read More »A Healthy Trade (In More Ways Than One)
After finding itself among the most oversold sectors last year, biotech is having its best start to a year since 2012 – a rally fueled… Read More »Biotech Is On The Mend
This biotech company’s drug for treating hypoactive sexual desire disorder in women is expected to receive FDA approval in early January 2019. With increasing market… Read More »The New – And More Effective – Female Viagra: An Attractive Opportunity?
There are very few diseases for which actual cures have been developed – but that could soon start to change. And with a “golden age… Read More »The New Paradigm For Biotech Investing
As the second-quarter earnings season gets underway, these three healthcare stocks – including a biotech that now has a near monopoly on the cystic fibrosis… Read More »Tip Top Healthcare Bets From Top Analysts